|
R&D Pipeline News, Volume 3, Issue 45: HIV Fusion & Entry Inhibitors |
|
|
|
19 Nov 2007 |
|
Read the highlights of the most recent edition of our weekly R&D information product R&D Pipeline News. The Special Product or Technology Pipelines of R&D Pipeline News are available via subscription of R&D Pipeline News or as a single Competitor Analysis.
Volume 3, Issue 45: HIV Fusion & Entry Inhibitors
Target Pipeline:
Company Pipeline:
More Details inside R&D Pipeline News
Get your annual subscription and receive this issue for free!
R&D Pipeline News
Get your Subscription Now
R&D Pipeline News is a premier information source about research and development (R&D) projects in the pipeline of the biopharmaceutical industry and is directed to all stakeholders in R&D . R&D Pipeline News covers all relevant treatment modalities, including. drugs, medical devices, biomaterials, combination products, cell therapy and drug delivery products.
- The Technology Edition lists the News in groups according to the product category, e.g. antibodies or vaccines etc. The product is delivered every week as a PDF directly to your desktop via e-mail.
- The Therapeutic Area Edition lists the News in groups according to the Therapautic Area, e.g. oncology, neurology, etc
- Or Get a 3-weeks free trial
|